Astaxanthin improves osteopenia caused by aldehyde-stress resulting from Aldh2 mutation due to impaired osteoblastogenesis
Hiroko Hoshi(Japanese Red Cross Narita Hospital), Takeshi Miyamoto(Kumamoto Health Science University), Ikuroh Ohsawa(Tokyo Metropolitan Institute of Gerontology), Shigeo Ohta(Nippon Medical School), Fuka Monoe(Maebashi Institute of Technology)
Cited by 20
Related Papers
DC-STAMP is essential for cell–cell fusion in osteoclasts and foreign body giant cells
|The Journal of Experimental Medicine|2005|899
Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis
|Cell Metabolism|2006|771
Commitment and Differentiation of Osteoclast Precursor Cells by the Sequential Expression of C-Fms and Receptor Activator of Nuclear Factor κb (Rank) Receptors
|The Journal of Experimental Medicine|1999|694
v-ATPase V0 subunit d2–deficient mice exhibit impaired osteoclast fusion and increased bone formation
|Nature Medicine|2006|542
Mitochondrial Genome Variation in Eastern Asia and the Peopling of Japan
|Genome Research|2004|528